Zephyrnet Logo

Tag: Clinical Trial

Top News

Radiopharmaceuticals Are A Buzzy Area For Deal-Making

When reporting on startup investment, big funding rounds and M&A deals for pharmaceutical companies are pretty common. Rarely, however, does the top search result for...

FDA clears Clario’s SpiroSphere® with wireless ECG, streamlining data collection in clinical trials | BioSpace

With the FDA 510(k) clearance of the COR-12 wireless ECG device now integrated with the SpiroSphere®, sponsors can conduct comprehensive respiratory trials with cardiac...

Nanoparticles reprogram mouse immune systems to suppress food allergy

Jun 10, 2024 (Nanowerk News) Two doses of allergen-encapsulating nanoparticles delivered intravenously prevented anaphylaxis during a food allergy test in mice, according to a study...

FDA Accepts Eisai’s Filing of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

TOKYO and CAMBRIDGE, Mass., June 10, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that that the U.S. Food...

DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™) | BioSpace

SEOUL, South Korea, June 10, 2024 /PRNewswire/ -- DeepQure, a Seoul based medical device company with a novel, extravascular (laparoscopic approach) solution for renal...

Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024 | BioSpace

Management to host live webcast to discuss results on Tuesday, June 18th at 8:30 a.m. ET THE WOODLANDS, TX, June 10, 2024 (GLOBE NEWSWIRE) --...

Can Psychedelics Improve Mental Health? | Quanta Magazine

IntroductionDuring traumatic periods and their aftermath, our brains can fall into habitual ways of thinking that may be helpful in the short run but...

PathMaker Neurosystems Announces $2.16 Million Award from U.S. Department of Defense for ALS Clinical Trial | BioSpace

Federal Funding Supports PathMaker’s Continued Development of Company’s Non-Invasive Treatment Platform for Amyotrophic Lateral Sclerosis BOSTON, June 05, 2024 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc....

Best Practices for Developing Safety Profiles in Rare Disease Clinical Trials

In developing drugs for rare diseases, ensuring long-term patient safety is paramount. Unlike more common conditions, rare diseases present unique challenges that make creating...

NMPA Review Report Released for Medtronic’s Renal Denervation Device

The NMPA granted innovation approvals to Medtronic’s renal denervation device and issued a review report. This is the sixth report published this year for...

“LEQEMBI” Lecanemab) Approved for the Treatment of Alzheimer’s Disease in South Korea

TOKYO and CAMBRIDGE, Mass., May 28, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Food...

Latest Intelligence

spot_img
spot_img